No Data
No Data
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
Lifetech Scientific (HKG:1302) posted a net profit attributable to owners of about 263.2 million yuan for the year ended Dec. 31, 2023, down from 325.3 million yuan in the previous year, according to
Xianjian Technology (01302) announced annual results. Profit attributable to shareholders of 263 million yuan decreased by 19.09% year-on-year
According to the Zhitong Finance App, Xianjian Technology (01302) announced the results for the year ended December 31, 2023. The group obtained revenue of RMB 1,267 billion (same unit), an increase of 15.48% over the previous year; profit attributable to the company owners was 263 million yuan, a decrease of 19.09% over the previous year; and the basic profit per share was 6 points. According to the announcement, the increase in revenue was mainly due to increased revenue from sales of congenital heart disease occulators and laminated stents.
LIFETECH SCI: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
LifeTech Scientific Flags Significant Profit Drop in 2023
LifeTech Scientific (HKG:1302) expects to record a "significant" decline in net profit for the year ended December 2023 when compared to 2022, according to a Friday filing with the Hong Kong bourse. T
Xianjian Technology (01302) issued a profit warning. Annual net profit is expected to drop significantly year-on-year
Xianjian Technology (01302) announced that the Group's net profit for the year ended December 31, 2023 is expected to be 2...
先健科技:盈利預警
No Data